33.64
-0.0975(-0.29%)
Currency In USD
Address
419 Davis Drive
Morrisville, NC 27560
United States of America
Phone
919 328 4400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
170
First IPO Date
July 26, 2018
| Name | Title | Pay | Year Born |
| Dr. Roger A. Jeffs Ph.D. | Chief Executive Officer & Director | 1.22M | 1962 |
| Mr. Russell Schundler | General Counsel & Corporate Secretary | 729,796 | 1976 |
| Mr. Michael Kaseta | Chief Operating Officer & Chief Financial Officer | 835,940 | 1976 |
| Mr. Christian Perez Font | Senior Vice President, Chief Compliance Officer & Associate General Counsel | 0 | N/A |
| Mr. Michael Post | Senior Vice President of Marketing | 0 | N/A |
| Mr. Jason Adair | Chief Business Officer | 0 | 1972 |
| Ms. Sarah Krepp SPHR | Chief Human Resources Officer | 0 | N/A |
| Matt Snow | Senior Vice President of Sales | 0 | N/A |
| Mr. Scott Moomaw | Chief Commercial Officer | 0 | 1971 |
| Ms. Dana Boyle | Chief Accounting Officer | 0 | 1984 |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.